Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™ - clean ...

Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™ - clean power ...

Chart Industries, Inc. has announced a conference call scheduled for February 28, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year financial results for 2024. The earnings release ...

Shares of Chart rose during the quarter as the company reported strong financial results, importantly with free cash flow ahead of investor expectations. The fundamentals for the business continue ...

2025 at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results. Chart plans to issue its fourth quarter and full year 2024 earnings release prior to market open on ...

Chart Industries, Inc. is a global leader in the design, engineering, and manufacturing of process technologies and equipment for gas and liquid molecule handling for the Nexus of Clean™ - clean power ...

Based on the completed analysis of the 12-week results, Outlook Therapeutics plans to resubmit the Biologics License Application (BLA) for ONS-5010 in the first quarter of calendar 2025.